Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Keung

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Oncology (Williston Park, N.Y.)|January 22, 2016
Neoadjuvant Therapy for Soft-Tissue SarcomasMark Fairweather, Emily Keung, Chandrajit P Raut
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicitiesSalahaldin A Tahir, Jianjun Gao, Yuji Miura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in patients with Sarcoma (SIGNIOS)David S Moura, Jesus Lopez-Marti, Hussein Tawbi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2023
SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient SelectionAhsan S Farooqi, Alison K Yoder, Heather Y Lin, et al.
Cancers|November 13, 2021
Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade OutcomesRobert A Szczepaniak Sloane, Michael G White, Russell G Witt, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Oncology (Williston Park, N.Y.)|January 22, 2016
Neoadjuvant Therapy for Soft-Tissue SarcomasMark Fairweather, Emily Keung, Chandrajit P Raut
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicitiesSalahaldin A Tahir, Jianjun Gao, Yuji Miura, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2026
Validation of a seven-gene predictive SIGNature for the efficacy of Immuno-Oncology PD-1 inhibitors in patients with Sarcoma (SIGNIOS)David S Moura, Jesus Lopez-Marti, Hussein Tawbi, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 2023
SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient SelectionAhsan S Farooqi, Alison K Yoder, Heather Y Lin, et al.
Cancers|November 13, 2021
Identification of MicroRNA-mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade OutcomesRobert A Szczepaniak Sloane, Michael G White, Russell G Witt, et al.
Pageof 1